Literature DB >> 7533360

Hyperlipidemia after liver transplantation: long-term results of the FK506/cyclosporine A US Multicenter Trial. US Multicenter Study Group.

M S Abouljoud1, M F Levy, G B Klintmalm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7533360

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  9 in total

Review 1.  Calcineurin inhibitors and post-transplant hyperlipidaemias.

Authors:  R Moore; D Hernandez; H Valantine
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Lipoprotein-apolipoprotein changes in renal transplant recipients.

Authors:  Maurizio Cassader; Gianluca Ruiu; Roberto Gambino; Natalina Alemanno; Giorgio Triolo; Fabrizio Veglia; Gianfranco Pagano
Journal:  Lipids       Date:  2002-10       Impact factor: 1.880

3.  Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation.

Authors:  G L Plosker; R H Foster
Journal:  Drugs       Date:  2000-02       Impact factor: 9.546

Review 4.  Chimerism-based tolerance in organ transplantation: preclinical and clinical studies.

Authors:  T Oura; A B Cosimi; T Kawai
Journal:  Clin Exp Immunol       Date:  2017-04-20       Impact factor: 4.330

5.  What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

Authors:  A Jain; J Reyes; R Kashyap; S Rohal; K Abu-Elmagd; T Starzl; J Fung
Journal:  Ann Surg       Date:  1999-09       Impact factor: 12.969

Review 6.  Tacrolimus. An update of its pharmacology and clinical efficacy in the management of organ transplantation.

Authors:  C M Spencer; K L Goa; J C Gillis
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 7.  Clinical pharmacokinetics and pharmacodynamics of tacrolimus in solid organ transplantation.

Authors:  Christine E Staatz; Susan E Tett
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

8.  Importance of Hematopoietic Mixed Chimerism for Induction of Renal Allograft Tolerance in Nonhuman Primates.

Authors:  Cornelius C Thaiss; Tetsu Oura; Hajime Sasaki; Abbas Dehnadi; Masatoshi Matsunami; Ivy A Rosales; A Benedict Cosimi; Tatsuo Kawai
Journal:  Transplantation       Date:  2019-04       Impact factor: 4.939

Review 9.  Cardiovascular effects of immunosuppression agents.

Authors:  Aly Elezaby; Ryan Dexheimer; Karim Sallam
Journal:  Front Cardiovasc Med       Date:  2022-09-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.